OpenResearchAlpha

Clinical Cancer Research · 17 Nov 2026

Molecular determinants of antibody-mediated priming to enhance detection of ctDNA

Shervin Tabrizih-index 19, Claire Sullivan, Kasturi Chakraborty, Carmen Martin-Alonso, Zhenyi An, Lily Gao, Daniel M. Kim, Savan K. Patel, Timothy Blewett, Justin Rhoades, Ruolin Liu, Sahil Patel, Kan Xiong, Andjela Crnjac, Sangeeta N. Bhatia, Viktor A. Adalsteinsson, J. Christopher Loveh-index 42

0
Citations
no database records one yet
0
Citations in 2026
so far
42
Leading author's h-index
J. Christopher Love, in QAI's scholar index
0
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0
  • Europe PMC0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

Abstract Purpose: Liquid biopsies can enable cancer detection and monitoring yet remain limited by low amounts of ctDNA. To address this limitation, we previously introduced a monoclonal antibody (mAb) “priming agent” that transiently increased the amount of ctDNA in blood. Here, we investigated the molecular features in both the agent and the target that drive this effect. Experimental Design: We developed a panel of novel mAbs and other cfDNA-binding agents and characterized their interaction with cfDNA, impact on cfDNA clearance, ability to increase ctDNA recovery, and impact on cfDNA fragmentation and composition in tumor bearing mice. Results: mAbs targeting either dsDNA or intact mononucleosomes increased the recovery of cfDNA and ctDNA without changing tumor fraction. mAbs with high avidity to dsDNA performed best, highlighting dsDNA as the key structural target for priming agents. One agent preserved short molecules of cfDNA associated with transcription factor binding sites and typically depleted at baseline. The Fc domain was not required for a measurable priming effect, as F(ab’)2 retained priming activity. Leveraging these insights, we engineered single-chain agents using the dsDNA binding domain sso7d, expanding priming strategies beyond immunoglobulins. Conclusions: This study identifies the molecular features and general design principles for mAb-based priming agents to enhance recovery and detection of ctDNA.

What the data shows

  • No database records a citation yet, as is usual for a paper this new.
  • J. Christopher Love has the highest h-index among the authors (42).

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (17)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (0)

What it cites, from open citation data, with Crossref's record of each.

No references in the open citation data yet.